CVS · Large Cap · NYSE · Healthcare · Healthcare Plans
Free research brief
Free to track. No card required.
Price, momentum, and the numbers behind the story.
Overall score
56/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Current price
$92.88
Lowest
$103
Median target
$116
Highest
$148
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Forward P/E
Favorable · 35% below avg
11.42x
Price / sales
Strong · Low price-to-sales
0.29x
Price / FCF
Strong · Cash flow supports price
10.12x
EV / EBITDA
Strong · Earnings support price
10.87x
ROIC
Weak · Weak capital efficiency
7.2%
ROE
Needs attention · Unfavorable
6.2%
Current ratio
Weak · Low cash for bills
0.87x
CVS against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $118.97B | 24.6 | +7.4% | 56 | |
| $34.85B | 36.5 | +15.5% | 78 | |
| $11.67B | 22.2 | +19.7% | 78 | |
| $4.35B | 13.1 | +13.5% | 77 | |
| $1.18T | 42.7 | +49.6% | 76 |